🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study evaluates the safety, tolerability, maximum tolerated dose (MTD)...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-03-01
Trial ID
NCT07339839
Treatments Being Tested
To assess safety, tolerability, PK, efficacy and determine recommended phas...
Status
Active Not Recruiting
Location
Beijing Cancer Hospital
Start Date
2021-07-26
Trial ID
NCT05009329
This is a multicenter, open-label phase 2 study that will enroll KRASG12C m...
Status
Recruiting
Location
The First Affiliated Hospital of Anhui Medical University
Start Date
2025-09-22
Trial ID
NCT07164170
Treatments Being Tested
The study is being conducted to evaluate the efficacy, and safety of HRS-70...
Status
Not Yet Recruiting
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2026-06
Trial ID
NCT07601048
Treatments Being Tested
Patients with other advanced solid tumors (excluding NSCLC and CRC) who hav...
Status
Recruiting
Location
Anhui Provincial Cancer Hospital
Start Date
2023-10-27
Trial ID
NCT06008288
Treatments Being Tested
This is a multicenter, single-arm, phase II (Simon two-stage) prospective i...
Status
Recruiting
Location
2nd Affiliated Hospital, School of Medicine
Start Date
2026-04-01
Trial ID
NCT07670013
This umbrella trial directed by next generation sequencing (NGS) includes p...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2024-11-01
Trial ID
NCT06563999